TuHURA BIOSCIENCES, INC./NV Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
TuHURA BIOSCIENCES, INC./NV (HURA) had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $93.02 thousand as of 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2016-05-12
- 2016-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $93.02K.
- 2015-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $12.26K.
- 2015-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $24.03K.
- 2015-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $127.20K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2016-03-31 | $93.02K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $12.26K 10-Q · filed 2016-02-12 |
| 2015-09-30 | $24.03K 10-Q · filed 2015-11-16 |
| 2015-03-31 | $127.20K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $80.09K 10-Q · filed 2015-02-12 |
| 2014-09-30 | $93.64K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $130.05K 10-K · filed 2014-08-28 |
| 2014-03-31 | $274.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $456.30K 10-K · filed 2014-03-10 |
| 2013-09-30 | $862.35K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $287.07K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $190.40K 10-Q · filed 2013-05-15 |
| 2012-03-31 | $191.38K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |